NCT00774397 · Interventional trial
Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)
Overall registry status Completed
Phase 2
Conditions Hepatitis C, Chronic
Delaware Valley sites
- 1220.5.0007 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory